002566 益盛药业
已收盘 07-23 15:00:00
资讯
新帖
简况
益盛药业:截止到2024年7月10日,公司股东总户数为23693户
证券之星 · 07-15
益盛药业:截止到2024年7月10日,公司股东总户数为23693户
益盛药业(002566)6月20日股东户数2.41万户,较上期减少1.61%
证券之星 · 06-28
益盛药业(002566)6月20日股东户数2.41万户,较上期减少1.61%
益盛药业:公司正积极拓展销售渠道,努力提升业绩回报投资者
证券之星 · 06-03
益盛药业:公司正积极拓展销售渠道,努力提升业绩回报投资者
益盛药业:将参加“2024年吉林辖区上市公司网上集体业绩说明会”
中国财富通 · 05-27
益盛药业:将参加“2024年吉林辖区上市公司网上集体业绩说明会”
益盛药业:2023年四季度营业收入和利润增长的原因主要系管理费用同比下降,投资收益同比增加所致
证券之星 · 05-09
益盛药业:2023年四季度营业收入和利润增长的原因主要系管理费用同比下降,投资收益同比增加所致
益盛药业(002566)4月26日主力资金净买入531.23万元
证券之星 · 04-26
益盛药业(002566)4月26日主力资金净买入531.23万元
益盛药业(002566.SZ)发布一季度业绩,净利润2101.64万元,下降26.78%
智通财经 · 04-25
益盛药业(002566.SZ)发布一季度业绩,净利润2101.64万元,下降26.78%
公司概况
公司名称:
吉林省集安益盛药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-03-18
主营业务:
吉林省集安益盛药业股份有限公司主营业务为药品的研发、生产和销售。公司主要产品有振源胶囊、心悦胶囊、生脉注射液、消痔灵注射液、红参饮片、西洋参饮片、红参麦冬膏、红参精提浓缩液、爱润、大阳英雄、益参妮奥系列化妆品、奢莲系列化妆品、菲露爱尔系列化妆品。益盛汉参种植基地是我国第一家获得GAP认证的非林地人参种植基地,被吉林省农业委员会认定为“长白山人参”品牌原料生产基地和良种繁育基地,益盛汉参牌人参及其制品被国家质检总局认定为生态原产地保护产品。
发行价格:
39.90
{"stockData":{"symbol":"002566","market":"SZ","secType":"STK","nameCN":"益盛药业","latestPrice":6.1,"timestamp":1721718189000,"preClose":6.23,"halted":0,"volume":2141700,"delay":0,"floatShares":231999999,"shares":331000000,"eps":0.2631,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.13,"latestTime":"07-23 15:00:00","open":6.2,"high":6.28,"low":6.09,"amount":13251600,"amplitude":0.0305,"askPrice":6.11,"askSize":335,"bidPrice":6.1,"bidSize":75,"shortable":0,"etf":0,"ttmEps":0.2631,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"adjPreClose":6.23,"symbolType":"stock","openAndCloseTimeList":[[1721698200000,1721705400000],[1721710800000,1721718000000]],"highLimit":6.85,"lowLimit":5.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":330951600,"pbRate":0.91,"roa":"--","roe":"0.94%","epsLYR":0.2862,"committee":-0.125461,"marketValue":2019000000,"floatMarketCap":1414000000,"peRate":23.185101,"changeRate":-0.0209,"turnoverRate":0.0092,"status":1},"requestUrl":"/m/hq/s/002566/wiki","defaultTab":"wiki","newsList":[{"id":"2451619803","title":"益盛药业:截止到2024年7月10日,公司股东总户数为23693户","url":"https://stock-news.laohu8.com/highlight/detail?id=2451619803","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451619803?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:03","pubTimestamp":1721034231,"startTime":"0","endTime":"0","summary":"证券之星消息,益盛药业(002566)07月15日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘: 你好 非常感谢你们不厌其烦回答投资者的提问。请问2024年7月10日股东人数是多少?谢谢益盛药业董秘:您好,截止到2024年7月10日,公司股东总户数为23693户,谢谢!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500022705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002566","BK0239"],"gpt_icon":0},{"id":"2446573719","title":"益盛药业(002566)6月20日股东户数2.41万户,较上期减少1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446573719","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446573719?lang=zh_cn&edition=full","pubTime":"2024-06-28 16:59","pubTimestamp":1719565180,"startTime":"0","endTime":"0","summary":"证券之星消息,近日益盛药业披露,截至2024年6月20日公司股东户数为2.41万户,较5月31日减少393.0户,减幅为1.61%。在中药行业个股中,益盛药业股东户数低于行业平均水平,截至6月20日,中药行业平均股东户数为5.1万户。从股价来看,2024年5月31日至2024年6月20日,益盛药业区间跌幅为10.61%,在此期间股东户数减少393.0户,减幅为1.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800036479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002566"],"gpt_icon":0},{"id":"2440468037","title":"益盛药业:公司正积极拓展销售渠道,努力提升业绩回报投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2440468037","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440468037?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:05","pubTimestamp":1717409116,"startTime":"0","endTime":"0","summary":"证券之星消息,益盛药业06月03日在投资者关系平台上答复投资者关心的问题。谢谢益盛药业董秘:您好,截止到5月31日,公司股东总户数为24472户,谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300023126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002566","BK0239"],"gpt_icon":0},{"id":"2438871905","title":"益盛药业:将参加“2024年吉林辖区上市公司网上集体业绩说明会”","url":"https://stock-news.laohu8.com/highlight/detail?id=2438871905","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438871905?lang=zh_cn&edition=full","pubTime":"2024-05-27 15:07","pubTimestamp":1716793674,"startTime":"0","endTime":"0","summary":"中国财富通5月27日 - 益盛药业(002566)公告称,为进一步加强与投资者的互动交流,公司将参加由吉林证监局、吉林省证券业协会、深圳市全景网络有限公司共同举办的“2024年吉林辖区上市公司网上集体业绩说明会”,时间为2024年5月29日(星期三)15:00至16:30。届时公司总经理薛晓民、董事会秘书李铁军、财务总监毕建涛将通过网络在线问答互动的形式,与投资者就2023年经营业绩等投资者关注的问题进行交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=yfqERpPLnsU%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","002566","BK0239"],"gpt_icon":0},{"id":"2434696066","title":"益盛药业:2023年四季度营业收入和利润增长的原因主要系管理费用同比下降,投资收益同比增加所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2434696066","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434696066?lang=zh_cn&edition=full","pubTime":"2024-05-09 17:03","pubTimestamp":1715245414,"startTime":"0","endTime":"0","summary":"证券之星消息,益盛药业(002566)05月09日在投资者关系平台上答复投资者关心的问题。投资者:您好,请介绍下2023年第四季度营业收入和利润率大幅提升的原因。谢谢!益盛药业董秘:您好,2023年四季度营业收入和利润增长的原因主要系管理费用同比下降,投资收益同比增加所致,谢谢!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900030760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002566"],"gpt_icon":0},{"id":"2430553243","title":"益盛药业(002566)4月26日主力资金净买入531.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430553243","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430553243?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:23","pubTimestamp":1714116234,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月26日收盘,益盛药业报收于6.86元,下跌3.65%,换手率5.33%,成交量12.35万手,成交额8376.93万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:益盛药业2024年一季报显示,公司主营收入2.0亿元,同比下降20.16%;归母净利润2101.64万元,同比下降26.78%;扣非净利润1809.48万元,同比下降15.11%;负债率22.96%,投资收益197.49万元,财务费用-91.47万元,毛利率76.85%。益盛药业主营业务:药品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600028637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002566","BK0028"],"gpt_icon":0},{"id":"2430420619","title":"益盛药业(002566.SZ)发布一季度业绩,净利润2101.64万元,下降26.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430420619","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430420619?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:27","pubTimestamp":1714033650,"startTime":"0","endTime":"0","summary":"智通财经APP讯,益盛药业(002566.SZ)发布2024年一季度报告,报告期内实现营业收入2亿元,同比下降20.16%。归属于上市公司股东的净利润2101.64万元,同比下降26.78%。归属于上市公司股东的扣除非经常性损益的净利润1809.48万元,同比下降15.11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002566"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-03-18","address":"吉林省通化市集安市文化东路17-20号","stockEarnings":[{"period":"1week","weight":0.0147},{"period":"1month","weight":0.0048},{"period":"3month","weight":-0.0753},{"period":"6month","weight":-0.1583},{"period":"1year","weight":-0.2506},{"period":"ytd","weight":-0.2859}],"companyName":"吉林省集安益盛药业股份有限公司","boardCode":"AI0027","perCapita":"9783股","boardName":"医药制造业","registeredCapital":"33095万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 吉林省集安益盛药业股份有限公司主营业务为药品的研发、生产和销售。公司主要产品有振源胶囊、心悦胶囊、生脉注射液、消痔灵注射液、红参饮片、西洋参饮片、红参麦冬膏、红参精提浓缩液、爱润、大阳英雄、益参妮奥系列化妆品、奢莲系列化妆品、菲露爱尔系列化妆品。益盛汉参种植基地是我国第一家获得GAP认证的非林地人参种植基地,被吉林省农业委员会认定为“长白山人参”品牌原料生产基地和良种繁育基地,益盛汉参牌人参及其制品被国家质检总局认定为生态原产地保护产品。","serverTime":1721720110776,"listedPrice":39.9,"stockholders":"23693人(较上一季度减少1.60%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益盛药业(002566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益盛药业(002566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益盛药业,002566,益盛药业股票,益盛药业股票老虎,益盛药业股票老虎国际,益盛药业行情,益盛药业股票行情,益盛药业股价,益盛药业股市,益盛药业股票价格,益盛药业股票交易,益盛药业股票购买,益盛药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益盛药业(002566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益盛药业(002566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}